LIFELINE HLM, Türkiye’s first locally developed and domestically produced heart-lung machine developed by ASELSAN, is entering international markets. The company signed three export agreements in health technologies at the 58th MEDICA in Düsseldorf, Germany, one of the world’s largest medical fairs.
The agreement signed with MEDIAL GLOBAL covers the sale of LIFELINE HLM in 12 different countries. An agreement with KOÇ MEDİKAL BIÇAKCILAR also cleared the way for the device to be exported to five more countries. The third agreement, signed with France-based CITYCARE, covers the sale of ASELSAN’s HEARTLINE AED automated external defibrillator and its accessories.

Vital support during open-heart surgery
Developed by ASELSAN engineers, LIFELINE HLM temporarily takes over the patient’s heart and lung functions during open-heart surgery, maintaining blood circulation and oxygenation. The device supports surgical teams with its precision control systems, user-friendly interface, advanced sensor feedback and automatic calibration features, and has entered clinical use in Türkiye. Domestic production of the machine is important for reducing external dependence in health technologies.
HEARTLINE AED, which has so far been exported to 26 countries in more than 13,000 units, was designed for early intervention in cases of sudden cardiac arrest. The device determines whether a shock is needed using an advanced ECG analysis algorithm and offers fully and semi-automatic operating options, voice and visual guidance, and a metronome feature that supports chest compressions. Through its collaborations at the fair, ASELSAN aims to strengthen the presence of its health and life-support products in international markets.
Photos: ASELSAN.